Bellecapital’s Teva Pharmaceuticals TEVA Stock Holding History

Bellecapital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	+34,658	New	+$1.15M	0.19%	53
2022 Q1	–	Sell	-26,100	Closed	-$209K	–	214
2021 Q4	$209K	Hold	26,100	–	–	0.06%	186
2021 Q3	$254K	Hold	26,100	–	–	0.08%	169
2021 Q2	$258K	Hold	26,100	–	–	0.08%	164
2021 Q1	$301K	Hold	26,100	–	–	0.09%	154
2020 Q4	$252K	Buy	26,100 +10,100	+63%	+$96.8K	0.08%	163
2020 Q3	$144K	Hold	16,000	–	–	0.07%	160
2020 Q2	$197K	Hold	16,000	–	–	0.09%	154
2020 Q1	$144K	Buy	+16,000	New	+$164K	0.09%	145
2019 Q4	–	Sell	-16,000	Closed	-$110K	–	157
2019 Q3	$110K	Hold	16,000	–	–	0.07%	132
2019 Q2	$148K	Hold	16,000	–	–	0.09%	121
2019 Q1	$251K	Hold	16,000	–	–	0.16%	96
2018 Q4	$247K	Hold	16,000	–	–	0.18%	86
2018 Q3	$345K	Hold	16,000	–	–	0.23%	65
2018 Q2	$389K	Buy	+16,000	New	+$326K	0.28%	57
2016 Q4	–	Sell	-6,600	Closed	-$297K	–	88
2016 Q3	$297K	Hold	6,600	–	–	0.33%	51
2016 Q2	$325K	Hold	6,600	–	–	0.36%	44
2016 Q1	$340K	Buy	6,600 +1,900	+40%	+$111K	0.45%	39
2015 Q4	$309K	Buy	4,700 +700	+18%	+$43.3K	0.4%	42
2015 Q3	$226K	Hold	4,000	–	–	0.33%	41
2015 Q2	$236K	Hold	4,000	–	–	0.3%	45
2015 Q1	$249K	Hold	4,000	–	–	0.33%	43
2014 Q4	$230K	Hold	4,000	–	–	0.31%	48
2014 Q3	$215K	Hold	4,000	–	–	0.25%	48
2014 Q2	$210K	Hold	4,000	–	–	0.21%	66
2014 Q1	$211K	Buy	+4,000	New	+$185K	0.18%	73

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bellecapital's TEVA Position: Q2 2026 in Review

Bellecapital opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 34,658 shares worth $1.17M. The stake represents 0.19% of the portfolio and ranks #53 among its holdings. This is a return to the name: Bellecapital previously reported a position in TEVA as recently as Q4 2021.

Bellecapital first reported a position in TEVA in Q1 2014 and has held it in 26 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Bellecapital held 34,658 shares of Teva Pharmaceuticals worth $1.17M as of Q2 2026.
Teva Pharmaceuticals was a new Bellecapital position in Q2 2026.
Teva Pharmaceuticals made up 0.19% of Bellecapital's portfolio in Q2 2026, its #53 holding.
Bellecapital first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 26 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.